• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MAX 表达降低是间变大细胞淋巴瘤不良预后的新的潜在生物标志物。

Decreased MYC-associated factor X (MAX) expression is a new potential biomarker for adverse prognosis in anaplastic large cell lymphoma.

机构信息

Department of Pathology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.

Department of Pathology, Saitama Red Cross Hospital, Saitama, Japan.

出版信息

Sci Rep. 2020 Jun 25;10(1):10391. doi: 10.1038/s41598-020-67500-w.

DOI:10.1038/s41598-020-67500-w
PMID:32587329
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7316730/
Abstract

MYC-associated factor X (MAX) is a protein in the basic helix-loop-helix leucine zipper family, which is ubiquitously and constitutively expressed in various normal tissues and tumors. MAX protein mediates various cellular functions such as proliferation, differentiation, and apoptosis through the MYC-MAX protein complex. Recently, it has been reported that MYC regulates the proliferation of anaplastic large cell lymphoma. However, the expression and function of MAX in anaplastic large cell lymphoma remain to be elucidated. We herein investigated MAX expression in anaplastic large cell lymphoma (ALCL) and peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) and found 11 of 37 patients (30%) with ALCL lacked MAX expression, whereas 15 of 15 patients (100%) with PTCL-NOS expressed MAX protein. ALCL patients lacking MAX expression had a significantly inferior prognosis compared with patients having MAX expression. Moreover, patients without MAX expression significantly had histological non-common variants, which were mainly detected in aggressive ALCL cases. Immunohistochemical analysis showed that MAX expression was related to the expression of MYC and cytotoxic molecules. These findings demonstrate that lack of MAX expression is a potential poor prognostic biomarker in ALCL and a candidate marker for differential diagnosis of ALCL and PTCL-NOS.

摘要

MYC 相关因子 X(MAX)是碱性螺旋-环-螺旋亮氨酸拉链家族中的一种蛋白质,在各种正常组织和肿瘤中广泛且持续表达。MAX 蛋白通过 MYC-MAX 蛋白复合物介导多种细胞功能,如增殖、分化和凋亡。最近有报道称,MYC 调节间变大细胞淋巴瘤的增殖。然而,MAX 在间变大细胞淋巴瘤中的表达和功能仍有待阐明。我们在此研究了 MAX 在间变大细胞淋巴瘤(ALCL)和外周 T 细胞淋巴瘤、非特指型(PTCL-NOS)中的表达,发现 37 例 ALCL 患者中有 11 例(30%)缺乏 MAX 表达,而 15 例 PTCL-NOS 患者(100%)表达 MAX 蛋白。缺乏 MAX 表达的 ALCL 患者的预后明显比有 MAX 表达的患者差。此外,缺乏 MAX 表达的患者显著具有组织学上的非常见变体,主要在侵袭性 ALCL 病例中检测到。免疫组织化学分析表明,MAX 表达与 MYC 和细胞毒性分子的表达有关。这些发现表明,缺乏 MAX 表达是 ALCL 的一个潜在不良预后生物标志物,也是 ALCL 和 PTCL-NOS 鉴别诊断的候选标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c187/7316730/bf6579399700/41598_2020_67500_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c187/7316730/cdb0296d9352/41598_2020_67500_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c187/7316730/16e879d328f1/41598_2020_67500_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c187/7316730/d508cd0d9a91/41598_2020_67500_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c187/7316730/469e899d0605/41598_2020_67500_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c187/7316730/bf6579399700/41598_2020_67500_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c187/7316730/cdb0296d9352/41598_2020_67500_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c187/7316730/16e879d328f1/41598_2020_67500_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c187/7316730/d508cd0d9a91/41598_2020_67500_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c187/7316730/469e899d0605/41598_2020_67500_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c187/7316730/bf6579399700/41598_2020_67500_Fig5_HTML.jpg

相似文献

1
Decreased MYC-associated factor X (MAX) expression is a new potential biomarker for adverse prognosis in anaplastic large cell lymphoma.MAX 表达降低是间变大细胞淋巴瘤不良预后的新的潜在生物标志物。
Sci Rep. 2020 Jun 25;10(1):10391. doi: 10.1038/s41598-020-67500-w.
2
Clinical and prognostic differences between ALK-negative anaplastic large cell lymphoma and peripheral T cell lymphoma, not otherwise specified: a single institution experience.ALK阴性间变性大细胞淋巴瘤与外周T细胞淋巴瘤(非特指型)之间的临床及预后差异:单中心经验
Ann Hematol. 2016 Aug;95(8):1271-80. doi: 10.1007/s00277-016-2696-9. Epub 2016 May 21.
3
High intratumoural galectin-1 expression predicts adverse outcome in ALK ALCL and CD30 PTCL-NOS.高肿瘤内半乳糖凝集素-1 表达预示着间变性大细胞淋巴瘤和 CD30 阳性间变大细胞淋巴瘤的不良预后。
Hematol Oncol. 2020 Feb;38(1):59-66. doi: 10.1002/hon.2702. Epub 2020 Jan 1.
4
Diagnostic and prognostic implications of tumor expression of the GATA-3 gene in nodal peripheral T-cell lymphoma (nPTCL): Retrospective data from a Latin American cohort.GATA-3基因在淋巴结外周T细胞淋巴瘤(nPTCL)中的肿瘤表达的诊断和预后意义:来自拉丁美洲队列的回顾性数据。
Leuk Res. 2022 Mar;114:106794. doi: 10.1016/j.leukres.2022.106794. Epub 2022 Feb 1.
5
Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma.外周 T 细胞淋巴瘤、非特指型和间变性大细胞淋巴瘤中趋化因子受体(CXCR3 和 CCR4)和细胞毒性分子的表达与 ALK 阴性的关联。
Int J Hematol. 2010 Apr;91(3):426-35. doi: 10.1007/s12185-010-0513-0. Epub 2010 Mar 9.
6
ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.ALK-间变性大细胞淋巴瘤在临床和免疫表型上与ALK+间变性大细胞淋巴瘤及外周T细胞淋巴瘤(未另行指定)均不同:来自国际外周T细胞淋巴瘤项目的报告
Blood. 2008 Jun 15;111(12):5496-504. doi: 10.1182/blood-2008-01-134270. Epub 2008 Apr 2.
7
[Expression and clinical significance of Mcl-1 in T-cell non-Hodgkin's lymphoma].Mcl-1在T细胞非霍奇金淋巴瘤中的表达及临床意义
Ai Zheng. 2007 Apr;26(4):435-9.
8
Update on the Treatment of Anaplastic Large Cell Lymphoma.间变大细胞淋巴瘤的治疗进展。
Curr Hematol Malig Rep. 2018 Apr;13(2):135-141. doi: 10.1007/s11899-018-0436-z.
9
Cutaneous anaplastic large cell lymphoma and peripheral T-cell lymphoma NOS show distinct chromosomal alterations and differential expression of chemokine receptors and apoptosis regulators.皮肤间变大细胞淋巴瘤和外周 T 细胞淋巴瘤非特指型表现出明显的染色体改变,以及趋化因子受体和凋亡调节因子的差异表达。
J Invest Dermatol. 2010 Feb;130(2):563-75. doi: 10.1038/jid.2009.270. Epub 2009 Aug 27.
10
Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.乳房植入物相关间变性大细胞淋巴瘤:两种具有不同预后的独特临床病理变体。
Ann Oncol. 2016 Feb;27(2):306-14. doi: 10.1093/annonc/mdv575. Epub 2015 Nov 23.

引用本文的文献

1
The significance of T-BET-positive CD8 T-cells with diminished CD5 expression in Kikuchi-Fujimoto disease.具有减弱的 CD5 表达的 T-BET 阳性 CD8 T 细胞在组织细胞坏死性淋巴结炎中的意义。
J Clin Exp Hematop. 2024 Sep 28;64(3):183-190. doi: 10.3960/jslrt.24019. Epub 2024 Jul 31.
2
Placental transcriptome variation associated with season, location, and urinary prenatal pyrethroid metabolites of Thai farm-working women.与季节、地点和泰国务农女性尿中产前拟除虫菊酯代谢物相关的胎盘转录组变异。
Environ Pollut. 2024 May 15;349:123873. doi: 10.1016/j.envpol.2024.123873. Epub 2024 Mar 28.
3
Circadian clock-related genome-wide mendelian randomization identifies putatively genes for ulcerative colitis and its comorbidity.

本文引用的文献

1
Anaplastic large cell lymphoma with TP63 rearrangement: A dismal prognosis.伴有TP63重排的间变性大细胞淋巴瘤:预后不良。
Pathol Int. 2019 Mar;69(3):155-159. doi: 10.1111/pin.12758. Epub 2019 Feb 5.
2
Nuclear expression of Y box binding-1 is important for resistance to chemotherapy including gemcitabine in TP53-mutated bladder cancer.Y 盒结合蛋白-1 的核表达对于包括吉西他滨在内的化疗耐药性在 TP53 突变型膀胱癌中很重要。
Int J Oncol. 2017 Aug;51(2):579-586. doi: 10.3892/ijo.2017.4031. Epub 2017 Jun 7.
3
Stabilization of the c-Myc Protein by CAMKIIγ Promotes T Cell Lymphoma.
昼夜节律相关全基因组孟德尔随机化研究鉴定溃疡性结肠炎及其合并症的潜在候选基因。
BMC Genomics. 2024 Feb 1;25(1):130. doi: 10.1186/s12864-024-10003-z.
4
Potential Signature Therapeutic Biomarkers TOP2A, MAD2L1, and CDK1 in Colorectal Cancer: A Systems Biomedicine-Based Approach.结直肠癌潜在的治疗性生物标志物 TOP2A、 MAD2L1 和 CDK1:基于系统生物医学的方法。
Biochem Genet. 2024 Jun;62(3):2166-2194. doi: 10.1007/s10528-023-10544-0. Epub 2023 Oct 26.
5
miR-22 Suppresses EMT by Mediating Metabolic Reprogramming in Colorectal Cancer through Targeting MYC-Associated Factor X.miR-22 通过靶向 MYC 相关因子 X 调控代谢重编程抑制结直肠癌中的 EMT
Dis Markers. 2022 Aug 25;2022:7843565. doi: 10.1155/2022/7843565. eCollection 2022.
6
CD24 is a surrogate for 'immune-cold' phenotype in aggressive large B-cell lymphoma.CD24是侵袭性大B细胞淋巴瘤中“免疫冷”表型的替代标志物。
J Pathol Clin Res. 2022 Jul;8(4):340-354. doi: 10.1002/cjp2.266. Epub 2022 Mar 14.
7
Cytokines, Genetic Lesions and Signaling Pathways in Anaplastic Large Cell Lymphomas.间变性大细胞淋巴瘤中的细胞因子、基因损伤与信号通路
Cancers (Basel). 2021 Aug 24;13(17):4256. doi: 10.3390/cancers13174256.
钙调蛋白激酶IIγ(CAMKIIγ)对c-Myc蛋白的稳定作用促进T细胞淋巴瘤。
Cancer Cell. 2017 Jul 10;32(1):115-128.e7. doi: 10.1016/j.ccell.2017.06.001.
4
MAX inactivation is an early event in GIST development that regulates p16 and cell proliferation.MAX 失活是 GIST 发展过程中的早期事件,它调节 p16 和细胞增殖。
Nat Commun. 2017 Mar 8;8:14674. doi: 10.1038/ncomms14674.
5
C-MYC is related to GATA3 expression and associated with poor prognosis in nodal peripheral T-cell lymphomas.C-MYC与GATA3表达相关,并与淋巴结外周T细胞淋巴瘤的不良预后相关。
Haematologica. 2016 Aug;101(8):e336-8. doi: 10.3324/haematol.2016.143768. Epub 2016 May 5.
6
Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts.鉴定表达异常水平 ERBB4 转录本的新型 ALK 阴性 ALCL 亚类。
Blood. 2016 Jan 14;127(2):221-32. doi: 10.1182/blood-2014-12-614503. Epub 2015 Oct 13.
7
Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements.伴有DUSP22重排的ALK阴性间变性大细胞淋巴瘤的形态学特征
Am J Surg Pathol. 2016 Jan;40(1):36-43. doi: 10.1097/PAS.0000000000000500.
8
Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma.趋同突变和激酶融合导致间变性大细胞淋巴瘤中致癌性STAT3激活。
Cancer Cell. 2015 Apr 13;27(4):516-32. doi: 10.1016/j.ccell.2015.03.006.
9
Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma.IRF4 和 MYC 信号对间变大细胞淋巴瘤存活的必要作用。
Blood. 2015 Jan 1;125(1):124-32. doi: 10.1182/blood-2014-08-594507. Epub 2014 Oct 30.
10
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.ALK阴性间变性大细胞淋巴瘤是一种基因异质性疾病,临床结局差异很大。
Blood. 2014 Aug 28;124(9):1473-80. doi: 10.1182/blood-2014-04-571091. Epub 2014 Jun 3.